AE-IG

N/A

Report date: 2022/02/08 09:32:57

Base Information

Drug NameAE-IG

Drug Alias NameGenetic vaccineAE-IG

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA

Mechanisms of ActionRNA interferenceHelper-inducer T-lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsGenetic Diseases, Inborn

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAntigen Express Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsGenetic Diseases, Inborn

ATC CodeN/A